Impact Banner

Newsroom

Welcome to the OREF Newsroom where you'll find news and announcements by and about OREF. Contact our Communications team with questions or media requests.


Karen Pubentz
Vice President, Communications
pubentz@oref.org

Amy Kile
Marketing Communications Manager
kile@oref.org

Stephanie Vazquez
Marketing Communications Specialist
vazquez@oref.org

News & Press Releases

Featured Articles

Thomas K. Fehring, MD, Publishes Results of OREF-Funded Study in JBJS

Results of a multicenter randomized trial comparing one- and two-stage treatment for periprosthetic joint infection show promise.
8-29-26 | Updated: 11-20-2026

In 2015, Thomas K. Fehring, MD, received an OREF Clinical Research Grant in Hip and Knee Arthroplasty Infection to conduct a prospective, multicenter randomized trial comparing the results of one- and two-stage treatment for periprosthetic joint infection (PJI). A summary of the research Dr. Fehring conducted with the funding is available on the OREF website.

Results, published in the July 2026 issue of The Journal of Bone and Joint Surgery are promising, showing that when study protocols are followed, one-stage treatment for PJI is not inferior to two-stage treatment. Read the JBJS article.


 

Orthopaedic Partner News

OREF is pleased to share news from our orthopaedic partners.

 

Thomas K. Fehring, MD, Publishes Results of OREF-Funded Study in JBJS

Nov 20, 2026, 18:10 PM
Results of a multicenter randomized trial comparing one- and two-stage treatment for periprosthetic joint infection show promise.
Title : Thomas K. Fehring, MD, Publishes Results of OREF-Funded Study in JBJS
Post author :
Publish Date : 8-29-26

In 2015, Thomas K. Fehring, MD, received an OREF Clinical Research Grant in Hip and Knee Arthroplasty Infection to conduct a prospective, multicenter randomized trial comparing the results of one- and two-stage treatment for periprosthetic joint infection (PJI). A summary of the research Dr. Fehring conducted with the funding is available on the OREF website.

Results, published in the July 2026 issue of The Journal of Bone and Joint Surgery are promising, showing that when study protocols are followed, one-stage treatment for PJI is not inferior to two-stage treatment. Read the JBJS article.


 

Categories :
Thomas K. Fehring, MD OREF-funded research results
Related News and Press Releases
Load more comments
Comment by from